Skip to content

Efficacy and cost of Stevia rebaudiana Bertoni extract as adjunctive therapy in Sahrawi patients with Type 2 diabetes

Efficacy of Stevia rebaudiana Bertoni extract as adjunctive therapy in Sahraoui patients with Type 2 diabetes. A Randomized, Controlled, Cross-over, Double-Blind Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR201410000894447
Enrollment
79
Registered
2014-09-28
Start date
2013-01-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nutritional, Metabolic, Endocrine diabetes in developing countries

Interventions

refined sugar (99% sucrose)
stevia rebaudiana as sweetener

Sponsors

Angela Pallarés
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: inclusion criteria: (1) Type 2 diabetes treated with diet and/or oral agents; (2) development of diabetes in an age greater than 30 years; (3) diabetes duration greater than 1 year; and (4) body mass index between 25 and 42 kg/m2.

Exclusion criteria

Exclusion criteria: Exclusion criteria were: (1) insulin therapy within the last 6 months; (2) concomitant cardiovascular diseases, psychological disorders, neurological problems, kidney or other endocrine disease; (3) drug abuse; (4) any intercurrent acute illness; (5) fasting glucose levels below 4 or above 19 mmol/L on the day of the experiment; and (6) treatment with glucocorticoids.

Design outcomes

Primary

MeasureTime frame
Effect on hearth rate;Effect on blood pressure (systolic, diastolic, mean);Effect on blood glucose

Secondary

MeasureTime frame
Arterial hypotension (less than mmHg 90 systolic or 60 diastolic);Hipoglycemia (capillary glucose less than 3.3 mmol/L)

Countries

Morocco

Contacts

Public ContactGenís Carrasco

Clinical chief, statistics and communication

geniscarrasco@telefonica.net0034626550055

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026